Lapatinib Impurity 22 | CAS 231278-83-4 - Request Quote
Lapatinib Impurity 22
| SZ CAT No: | SZ-L036031 |
| CAS No | 231278-83-4 |
| Mol.F. | C26H18ClN3O3 |
| Mol.Wt. |
455.9 |
| Inv. Status |
In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Hazard Statement:
Usage Note:
Lapatinib Impurity 22 is chemically 5-(4-((4-(Benzyloxy)-3-chlorophenyl)amino)quinazolin-6-yl)furan-2-carbaldehyde. Lapatinib Impurity 22 is supplied with detailed characterization data compliant with regulatory guideline. Lapatinib Impurity 22 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lapatinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 231278-83-4
Purchase 231278-83-4
Order 231278-83-4
Enquire 231278-83-4
price of 231278-83-4
231278-83-4 Supplier
231278-83-4 Manufacturer
231278-83-4 Exporter
buy high quality Lapatinib Impurity 22
Purchase Lapatinib Impurity 22
Lapatinib Impurity 22 suppliers
Lapatinib Impurity 22 manufacturers
Lapatinib Impurity 22 price
Order Lapatinib Impurity 22
Enquire Lapatinib Impurity 22
Lapatinib Impurity 22 cost
Lapatinib Impurity 22 Supplier
Lapatinib Impurity 22 Distributor
Lapatinib Impurity 22 for Method Validation
Lapatinib Reference Standard
Lapatinib Impurity 22 for ANDA Filing
Lapatinib Impurity 22 for Forced Degradation Studies
Lapatinib Impurity 22 Identification Standards
Lapatinib Impurity 22 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.